Novavax, Inc. (NVAX) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

11/25

Growth 2 Margin 2 Expansion 3 Platform 2 Financial 2

latest quarter score

Earnings Reports

11
Novavax (NVAX) Q2 2026: Sanofi Partnership Unlocks $125M Milestone Catalyst, Expands Global Vaccine Reach
August 06, 2026
16
Novavax (NVAX) Q1 2026: Partner Revenue Surges 116% as MatrixM Adoption Accelerates
May 06, 2026
19
Novavax (NVAX) Q4 2025: R&D and SG&A Spend Slashed 53% as Matrix-M Partnerships Accelerate
February 26, 2026
11
Novavax (NVAX) Q3 2025: Sanofi Milestones Hit $225M as Platform Pivot Redefines Path to Profitability
November 06, 2025
13
Novavax (NVAX) Q2 2025: $175M Sanofi Milestone Triggers Leaner Model and Partnership Leverage
August 06, 2025
12
Novavax (NVAX) Q1 2025: Cost Base Down 24%, Platform Partnerships Expand as Revenue Framework Rises
July 07, 2025

Browse all companies